• 1
    Mantovani V, Maniscalco G, Borsani P, Tenconi S, Bruno VD, Leva C et al. Effects of adenosine and defibrotide adjunct to a standard crystalloid cardioplegic solution. J Cardiovasc Surg 2005;46:291296.
  • 2
    Besisik SK, Ozturk GB, Caliskan Y, Sargin D. Complete resolution of transplantation-associated thrombotic microangiopathty and hepatic veno-occlusive disease by defibrotide and plasma exchange. Turk J Gastroenterol 2005;16:3437.
  • 3
    Chalandon Y, Roosnek E, Mermillod B, Newton A, Ozsahin H, Wacker P et al. Prevention of veno-occlusive disease with defibrotide after allogenic stem cell transplantation. Biol Blood Marrow Transplant 2004;10:347354.
  • 4
    Burcoglu-O'Ral A, Erkan D, Asherson R. Treatment of catastrophic antiphospholipid syndrome with defibrotide, a proposed vascular endothelial cell modulator. J Rheumatol 2002;29:20062011.
  • 5
    Gelister JS, James WE, Fox JA. Preliminary experience with defibrotide in severe lower limb ischaemia. Haemostasis 1986;16(Suppl. 1):6366.
  • 6
    Brochow K, Romano A, Blanca M, Ring J, Picher WJ, Demoly P, ENDA. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002;57:4551.